GERN shares will boost to $30 or above next week Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : GERN shares will boost to $30 or above next week

GERN 1.235

0.0%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WhipsawMcGraw who wrote (13)	11/14/1998 5:03:00 PM
From: Jonathan Cleveland	Read Replies (1) of 21

Firt of all GERN has the patents which is more important than any drug. Merk etc. is not a player they can not conduct there own research, Gern has everything what they have done is more than just ground breaking its unbelievable. 80% percent of the research that comes out of merk like companies comes from third party sources. Gern holds the patents try to remember that.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next